Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?

被引:1
|
作者
Shalem, Tzippora [1 ]
Cohen, Daniel L. [2 ]
Epstein-Rigbi, Na'ama [3 ,4 ]
Elizur, Arnon [3 ,4 ]
Eindor-Abarbanel, Adi [1 ]
Broide, Efrat [1 ,2 ,4 ]
Richter, Vered [2 ,4 ]
机构
[1] Shamir Assaf Harofeh Med Ctr, Jecheskiel Sigi Gonczarowski Pediat Gastroenterol, IL-70300 Zerifin, Israel
[2] Shamir Assaf Harofeh Med Ctr, Gonczarowski Family Inst Gastroenterol & Liver Dis, IL-70300 Zerifin, Israel
[3] Shamir Assaf Harofeh Med Ctr, Inst Allergy Immunol & Pediat Pulm, Zerifin, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
Eosinophilic esophagitis (EoE); Oral immunotherapy (OIT); Proton pump inhibitor (PPI); Treatment efficacy; ALLERGY;
D O I
10.1007/s00431-023-05228-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Oral immunotherapy (OIT) may induce eosinophilic esophagitis (EoE). Proton pump inhibitors (PPIs) are an effective treatment for EoE. However, the effect of PPI treatment is not well established in patients with EoE induced by OIT. Our primary aim was to compare the clinical, endoscopic, and histological response rates to PPIs in children with EoE induced by OIT (EoE+OIT) versus EoE patients without OIT (EoE-OIT). The secondary aims are to describe the clinical and histological features of EoE+OIT. Demographic, clinical, endoscopic, and histological findings of patients with EoE in the gastroenterology clinic at Shamir Medical Center between March 2015 and December 2022 were collected. Comparisons were performed between EoE+OIT and EoE-OIT patients. The study included 42 children (74% male, mean age 11.2), of whom 31 had EoE-OIT and 11 had EoE+OIT. There were no significant differences between groups regarding sex, comorbidities, symptoms, or endoscopic and histological characteristics at diagnosis. All 42 children were treated with PPIs after diagnosis with or without diet changes. The rates of any clinical response were 83.9% and 90.1% in the EoE-OIT group and EoE+OIT group, respectively (p = 1.0). The rate of any endoscopic response was 74.2% for EoE-OIT and 81.8% for EoE+OIT (p = 0.54). Histologically, PPIs were even more effective in the EoE+OIT group, where only 18.2% had no histological response at all compared to 51.6% in the EoE-OIT group (p = 0.1).Conclusion: PPI treatment is as effective in EoE with OIT as it is in EoE due to other etiologies.What is Known:& BULL; Proton pump inhibitor (PPI) treatment is effective for achieving clinical response and histologic remission in some patients with eosinophilic esophagitis (EoE).& BULL; EoE has also been reported to be triggered by oral immunotherapy (OIT).What is New:& BULL; PPI treatment in EoE with OIT is as effective as treatment for EoE due to other etiologies.
引用
收藏
页码:5409 / 5416
页数:8
相关论文
共 50 条
  • [1] Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?
    Tzippora Shalem
    Daniel L. Cohen
    Na’ama Epstein-Rigbi
    Arnon Elizur
    Adi Eindor-Abarbanel
    Efrat Broide
    Vered Richter
    European Journal of Pediatrics, 2023, 182 : 5409 - 5416
  • [2] EOSINOPHILIC ESOPHAGITIS (EOE)
    Sauer, Bryan
    GASTROENTEROLOGY NURSING, 2020, 43 (02) : E71 - E71
  • [3] Triggers for eosinophilic esophagitis (EoE): The intersection of food allergy and EoE
    Burk, Caitlin M.
    Shreffler, Wayne G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (06) : 1500 - 1509
  • [4] Predictors of Increased Eosinophilic Esophagitis (EoE) Disease Activity After Proton Pump Inhibitor Therapy
    Wisner, Bennett
    Meyers, Derek
    Smith, Aaron
    Lyons, Catherine
    Barnes, Barrett
    Sauer, Bryan
    McGowan, Emily
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB201 - AB201
  • [5] Spotlight: Treatment of Eosinophilic Esophagitis (EoE)
    Hirano, Ikuo
    Sharaf, Ravi
    Stollman, Neil
    Wang, Kenneth
    Falck-Ytter, Yngve
    Chan, Edmond
    Rank, Matthew
    Stukus, David
    Greenhawt, Matthew
    GASTROENTEROLOGY, 2020, 158 (06) : 1788 - 1788
  • [6] A Mouse Model for Eosinophilic Esophagitis (EoE)
    Dsilva, Anish
    Avlas, Shmulik
    Rhone, Natalie
    Itan, Michal
    Munitz, Ariel
    CURRENT PROTOCOLS, 2024, 4 (02):
  • [7] Seeking care for eosinophilic esophagitis (EoE): Patients see multiple providers for EoE
    Jaffee, Hannah
    Strobel, Mary Jo
    Chang, Joy
    Holbreich, Mark
    Medernach, Jonathan
    Eftekhari, Sanaz
    Greenhawt, Matthew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB253 - AB253
  • [8] Eosinophil Degranulation Differentiates Eosinophilic Esophagitis (EoE), Possible EoE and GERD Patients
    Cobell, William J.
    Gleich, Gerald J.
    Thomas, Kristen
    Georgelas, Ann
    Leiferman, Kristin
    Clayton, Frederic
    Fang, John C.
    Peterson, Kathryn
    GASTROENTEROLOGY, 2009, 136 (05) : A279 - A279
  • [9] Eosinophilic esophagitis (EoE): Current developments in therapy
    Worm, M.
    Reese, I.
    ALLERGOLOGIE, 2024, 47 (02) : 61 - 68
  • [10] The faces of eosinophilic esophagitis (Eoe) in adults and children
    Almansa, Cristina
    Devault, Kenneth R.
    Buchner, Anna M.
    Achem, Sarni R.
    GASTROENTEROLOGY, 2007, 132 (04) : A609 - A610